Bharat Immunologicals Probability Of Bankruptcy

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Probability Of Bankruptcy Analysis

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis. The score is used to predict probability of a firm or a fund experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Bharat Immunologicals 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
11 %

About Probability Of Bankruptcy

Probability of Bankruptcy SHOULD NOT be confused with actual chance of a company to file for chapter 7, 11, 12 or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty to meet its current financial obligations towards its creditors or to deliver on the expectations of its investors. Macroaxis derives these conditions on a daily bases from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns including short term and long term historical volatility. Other factors taken into account include analysis of liquidity, revenues patterns, RND expenses, as well as public headlines and social sentiment.Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Probability Of Bankruptcy of 11.0%. This is much higher than that of the sector, and significantly higher than that of Probability Of Bankruptcy industry, The Probability Of Bankruptcy for all stocks is over 1000% lower than the firm.
< 11% 

Chance of Financial Distress

Bharat Immunologicals Biologicals Corp Ltd has less than 11 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Did you try this?

Run Fundamentals Comparison Now
   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
Hide  View All  Next  Launch Fundamentals Comparison
Return On Asset(1.69) %
Profit Margin(4.18) %
Operating Margin(5.13) %
Current Valuation862.5 M
Shares Outstanding43.18 M
Price to Earning(28.02) times
Price to Book2.50 times
Price to Sales0.66 times
Revenue1.28 B
Gross Profit119 M
EBITDA(56.51 M)
Net Income(53.46 M)
Cash and Equivalents152.27 M
Cash per Share3.55 times
Total Debt177.56 M
Debt to Equity0.50 times
Current Ratio1.69 times
Earnings Per Share(1.24) times
Market Capitalization1.5 B
Z Score4.8